Number of Panel Genes25

Connective Tissue Gene Tests offers five panel options for osteogenesis imperfecta (OI) testing utilizing NextGen sequencing technology, an OI COL1A1 & COL1A2 panel, an OI core panel, a dominant OI panel, a recessive OI panel and a combined dominant and recessive OI panel.  In addition to genes associated with the autosomal dominant and autosomal recessive forms of OI, the panels also contain genes for disorders included in the differential diagnosis of OI.

Connective Tissue Gene Tests offers five panel options for osteogenesis imperfecta (OI) testing utilizing NextGen sequencing technology, an OI COL1A1 & COL1A2 panel, an OI core panel, a dominant OI panel, a recessive OI panel and a combined dominant and recessive OI panel.  In addition to genes associated with the autosomal dominant and autosomal recessive forms of OI, the panels also contain genes for disorders included in the differential diagnosis of OI.

The combined dominant and recessive OI panel consist of twenty-five genes: ALPL, ANO5, BMP1, COL1A1, COL1A2, CREB3L1, CRTAP, FKBP10, IFITM5, LRP5, MBTPS2, P3H1, P4HB, PLOD2, PLS3, PPIB, SEC24D, SERPINF1, SERPINH1, SP7, SPARC, TAPT1, TMEM38B, WNT1 and XYLT2.

Copy number variation (CNV) analysis of the Osteogenesis imperfecta genes is also offered as a panel. Additionally, CTGT offers a comprehensive test (both NGS and CNV panels) for these genes. Panel genes are also offered as individual sequencing and deletion/duplication tests unless otherwise indicated.

OI, Dominant Panel
Gene Disorder MIM Inheritance
ALPL Hypophosphatasia, adult 146300 AD
ANO5 Gnathodiaphyseal dysplasia 166260 AD
COL1A1
Ehlers-Danlos syndrome, arthrochalasia type, 1 (EDSARTH1)
Osteogenesis imperfecta, type I (OI1)
Osteogenesis imperfecta, type II (OI2)
Osteogenesis imperfecta, type III (OI3)
Osteogenesis imperfecta, type IV (OI4)
130060
166200
166210
259420
166220
AD
COL1A2 Ehlers-Danlos syndrome, arthrochalasia type, 2 (EDSARTH2)
Osteogenesis imperfecta, type II (OI2)
Osteogenesis imperfecta, type III (OI3)
Osteogenesis imperfecta, type IV (OI4)
617821
166210
259420
166220
AD
IFITM5 Osteogenesis imperfecta, type V (OI5) 610967 AD
P4HB Cole-Carpenter syndrome 1 112240 AD
PLS3 PLS3 related Bone mineral density quantitative trait locus 18 (BMND18) 300910 XL
 

 

 

 

 

 

 

 

 

 

OI Recessive Panel
Gene Disorder MIM Inheritance
SERPINF1 Osteogenesis imperfecta, type VI (OI6) 613982 AR
CRTAP Osteogenesis imperfecta, type VII (OI7) 610682 AR
P3H1 (LEPRE1) Osteogenesis imperfecta, type VIII (OI8) 610915 AR
PPIB Osteogenesis imperfecta, type IX (OI9) 259440 AR
SERPINH1 Osteogenesis imperfecta, type X (OI10) 613848 AR
FKBP10 Osteogenesis imperfecta, type XI (OI11)
Bruck syndrome 1 (BRKS1)
610968
259450
AR
SP7 Osteogenesis imperfecta, type XII (OI12) 613849 AR
BMP1 Osteogenesis imperfecta, type XIII (OI13) 614856 AR
TMEM38B Osteogenesis imperfecta, type XIV (OI14) 615066 AR
WNT1 Osteogenesis imperfecta, type XV (OI15) 615220 AR
CREB3L1 Osteogenesis imperfecta, type XVI (OI16) 616229 AR
SPARC Osteogenesis imperfecta, type XVII (OI17) 616507 AR
ALPL Hypophosphatasia, adult
Hypophosphatasia, childhood
Hypophosphatasia, infantile
146300
241510
241500
AR
LRP5 Osteoporosis-pseudoglioma syndrome (OPPG) 259770 AR
MBTPS2 Osteogenesis imperfecta, MBTPS2 related - XLR
PLOD2 Bruck syndrome 2 (BRKS2) 609220 AR
PLS3 PLS3 related Bone mineral density quantitative trait locus 18 (BMND18) 300910 XL
SEC24D Cole-Carpenter syndrome 2 (CLCRP2) 616294 AR
TAPT1 Osteochondrodysplasia, complex lethal,
Symoens-Barnes-Gistelinck type (OCLSBG)
616897 AR
XYLT2 Spondyloocular syndrome (SOS) 605822 AR

 

 
 

Gene(s)

ALPL ANO5 BMP1 COL1A1 COL1A2 CREB3L1 CRTAP FKBP10 IFITM5 LRP5 MBTPS2 P3H1 P4HB PLOD2 PLS3 PPIB SEC24D SERPINF1 SERPINH1 SP7 SPARC TAPT1 TMEM38B WNT1 XYLT2

Disease Group

Skeletal disorders

MIM

166200 166210 259420 166220 610967 146300 613982 610682 610915 259440 613848 610968 613849 614856 615066 615220 609220 146300 241500 241510

Methodology

Billing

CPT Code(s)
81408 x 1, 81479 x 1, 81406 x 1

Ordering

Test Code
5102

Additional Test Codes
5100 —Next Generation Sequencing Only, 5101 — Deletion / Duplication Only

Turnaround Time
Typically 2 to 4 weeks from receipt of a sample in the laboratory. All cases involving ongoing pregnancies will be expedited.

Prenatal Specimens
Cultured cells: 2 confluent T-25 flasks derived from amnio or CVS samples
Genomic DNA: minimum of 3 µg (at a concentration of at least 30 ng/µl)

Non-Prenatal Specimens
Whole blood: purple-top (EDTA) tube, minimum of 3 ml
Genomic DNA: a minimum of 3 µg (at a concentration of at least 30 ng/µl)
Fibroblasts: 2 confluent T-25 flasks
Saliva: only samples collected in Oragene DNA Self-Collection Kit or Oragene Saliva Collection Kit for Young Children are accepted

Shipping
Ship all specimen types at room temperature by overnight courier. Do not freeze.

The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. HNL Lab Medicine strongly recommends confirmation of CPT codes with third-party payors and/or the AMA. We assume no responsibility for billing errors due to reliance upon CPT codes provided by HNL Lab Medicine.

What's New

October 13, 2021

CTGT.net: A New Website Experience

We've refreshed our look and feel to better meet your needs. 

CTGT's new website is not only user-friendly but also provides more advanced test search capabilities, additional methodologies, and a clean design suited for multi-platform usage.

Read More
September 28, 2021

9 New Tests for Genetic Carrier Screening Panels

CTGT is now offering 9 NEW tests for Genetic Carrier Screening. 
Read More
September 25, 2021

New York State Clinical Laboratory Permit Approval

CTGT is proud to announce that its CLIA licensed and CAP-accredited Pennsylvania laboratory has earned a New York State Department of Health clinical laboratory permit to perform genetic testing for patients residing within the state of New York. 
Read More
September 23, 2021

California Department of Public Health Clinical Laboratory License Approval

CTGT is proud to announce that its CLIA licensed and CAP-accredited Pennsylvania laboratory is now licensed by the California Department of Public Health to perform genetic testing for patients residing within the state of California. 
Read More
September 20, 2021

Patient Insurance Billing, Prior Authorization, and Benefit Investigation

CTGT is dedicated to providing accessible, affordable, and high-quality lab services.
Read More